NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $221,000 | +7.3% | 2,341 | -1.3% | 0.01% | 0.0% |
| Q3 2020 | $206,000 | -47.8% | 2,371 | -47.6% | 0.01% | -54.5% |
| Q2 2020 | $395,000 | -4.6% | 4,521 | -10.0% | 0.02% | -18.5% |
| Q1 2020 | $414,000 | -12.3% | 5,021 | +0.7% | 0.03% | +8.0% |
| Q4 2019 | $472,000 | +1.5% | 4,986 | -6.8% | 0.02% | -7.4% |
| Q3 2019 | $465,000 | +17.1% | 5,347 | +23.0% | 0.03% | +17.4% |
| Q2 2019 | $397,000 | -6.6% | 4,347 | -1.7% | 0.02% | -11.5% |
| Q1 2019 | $425,000 | +12.1% | 4,420 | 0.0% | 0.03% | -3.7% |
| Q4 2018 | $379,000 | -0.5% | 4,420 | -0.0% | 0.03% | +17.4% |
| Q3 2018 | $381,000 | -48.1% | 4,422 | -52.8% | 0.02% | -4.2% |
| Q2 2018 | $734,000 | +88.2% | 9,378 | +94.2% | 0.02% | -7.7% |
| Q1 2018 | $390,000 | -7.4% | 4,829 | -3.6% | 0.03% | -10.3% |
| Q4 2017 | $421,000 | +75.4% | 5,010 | +79.2% | 0.03% | +20.8% |
| Q4 2015 | $240,000 | +15.9% | 2,795 | +24.3% | 0.02% | +9.1% |
| Q3 2015 | $207,000 | – | 2,249 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |